Shilpa Medicare (BOM:530549) Cyclically Adjusted PB Ratio: (As of Sep. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530549 Shilpa Medicare Ltd BOM:530549
73 GF Score
Price ₹961.85
GF Value ₹456.81
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Shilpa Medicare Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Shilpa Medicare  (BOM:530549) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shilpa Medicare Cyclically Adjusted PB Ratio Related Terms


Shilpa Medicare Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Shilpa Medicare's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shilpa Medicare Cyclically Adjusted PB Ratio Chart

Shilpa Medicare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.84 1.42 2.56 3.34 3.18

Shilpa Medicare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.58 0.00 3.18 0.00

BOM:530549 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shilpa Medicare Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shilpa Medicare's Cyclically Adjusted PB Ratio falls into.


BOM:530549
73GF Score
Shilpa Medicare Ltd BOM:530549
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shilpa Medicare Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shilpa Medicare's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Shilpa Medicare's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Shilpa Medicare Quarterly Data

Book Value per Share CPI Adj_Book
201609 43.366 105.961 68.493
201612 0.000 105.196 0.000
201703 61.583 105.196 97.973
201706 0.000 107.109 0.000
201709 60.719 109.021 93.209
201712 0.000 109.404 0.000
201803 66.544 109.786 101.439
201806 0.000 111.317 0.000
201809 71.190 115.142 103.474
201812 0.000 115.142 0.000
201903 73.447 118.202 103.990
201906 0.000 120.880 0.000
201909 76.976 123.175 104.587
201912 0.000 126.235 0.000
202003 81.529 124.705 109.414
202006 0.000 127.000 0.000
202009 89.602 130.118 115.246
202012 0.000 130.889 0.000
202103 90.686 131.771 115.177
202106 0.000 134.084 0.000
202109 91.878 135.847 113.190
202112 0.000 138.161 0.000
202203 104.963 138.822 126.539
202206 0.000 142.347 0.000
202209 103.502 144.661 119.741
202212 0.000 145.763 0.000
202303 102.721 146.865 117.054
202306 0.000 150.280 0.000
202309 102.732 151.492 113.491
202312 0.000 152.924 0.000
202403 104.185 153.035 113.936
202406 0.000 155.789 0.000
202409 119.023 157.882 126.166
202412 0.000 158.323 0.000
202503 120.804 157.552 128.323
202506 0.000 159.755 0.000
202509 124.613 162.289 128.505
202512 0.000 163.281 0.000
202603 132.487 164.272 134.975
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Shilpa Medicare (BOM:530549) Overvalued in 2026?

Based on GuruFocus' analysis, Shilpa Medicare stock appears to be overvalued. The current stock price of ₹961.85 is trading 110.6% above its estimated GF Value™ of ₹456.81. GuruFocus considers Shilpa Medicare to be Significantly Overvalued.

Key valuation signals for BOM:530549:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹456.81 vs. price of ₹961.85 (110.6% above fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the BOM:530549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shilpa Medicare Business Description

Other Exchanges SHILPAMED:India
Address Hyderabad Road, No. 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
73GF Score

Get the complete analysis for BOM:530549

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹961.85
Price
₹456.81
GF Value